Methyl 7-fluoro-2-(methoxymethyl)-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylate

Catalog No. :
ACPQZI154
CAS No. :
338778-13-5
Molecular Formula :
C16H12FNO5
Molecular Weight :
317.27

IUPAC Name:methyl 7-fluoro-2-(methoxymethyl)-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylate

Methyl 7-fluoro-2-(methoxymethyl)-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$324.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 7-fluoro-2-(methoxymethyl)-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylate
IUPAC Namemethyl 7-fluoro-2-(methoxymethyl)-5-oxo-5H-chromeno[2,3-b]pyridine-3-carboxylate
MDL No.MFCD00139064
Molecular FormulaC16H12FNO5
Molecular Weight317.27
SMILESO=C(C1=C(COC)N=C2C(C(C3=C(O2)C=CC(F)=C3)=O)=C1)OC
InChI KeyZULOOWGURHYWAG-UHFFFAOYSA-N
Synonym5H-[1]Benzopyrano[2,3-b]pyridine-3-carboxylic acid, 7-fluoro-2-(methoxymethyl)-5-oxo-, methyl ester
CAS No.338778-13-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACPQZI154 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPQZI154 route product structure diagram
    ACPQZI154338778-13-5
Inquiry

2. ACPQZI154 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  4. Then
  5. ACPQZI154 route product structure diagram
    ACPQZI154338778-13-5
Inquiry

Comments (0)